Hess F, Steeghs S, Braun B, van Det R, Grande P, Jerusalem C, Skotnicki S
Laboratory for Cell Biology and Histology, Catholic University of Nijmegen, The Netherlands.
Thorac Cardiovasc Surg. 1988 Aug;36(4):221-6. doi: 10.1055/s-2007-1020083.
Segments of 3 mm diameter fibrous polyurethane vascular prosthesis of length 3-4 cm were prepared. They were bilaterally implanted in the carotid and femoral arteries of male and female beagles. Four groups consisting of animals receiving either no medication or thrombocyte aggregation drugs were studied: Group A (8 dogs), no medication: group B (19 dogs), 500 mg acetylsalicylic acid (ASA) once daily and 25 mg dipyridamol (DIP) three times daily orally for 6 weeks after the implantation operation; group C (14 dogs), 250 mg ASA and 25 mg DIP three times daily orally for 6 weeks after the implantation operation; group D (12 dogs), 250 mg ASA and 25 mg DIP three times daily orally for 25 weeks after the implantation operation. Medication was started one week prior to the implantation operation. In group A, all prostheses were occluded at week 6. There was a significant difference in patency rates between groups B-D and C-D. No significant differences in patency rates could be found between groups B and C. The best patency rates were obtained 25 weeks after implantation in group D for both the right and left carotid and right and left femoral implantation sites. Highest patency rates were observed when ASA and DIP were given for 25 weeks.
制备了直径3毫米、长度3 - 4厘米的纤维聚氨酯血管假体节段。将其双侧植入雄性和雌性比格犬的颈动脉和股动脉。研究了四组动物,分别为未接受任何药物治疗或接受血小板聚集药物治疗的动物:A组(8只犬),未用药;B组(19只犬),植入手术后每天口服一次500毫克乙酰水杨酸(ASA)和每天三次25毫克双嘧达莫(DIP),持续6周;C组(14只犬),植入手术后每天口服三次250毫克ASA和25毫克DIP,持续6周;D组(12只犬),植入手术后每天口服三次250毫克ASA和25毫克DIP,持续25周。在植入手术前一周开始用药。在A组中,所有假体在第6周时均发生阻塞。B - D组和C - D组之间的通畅率存在显著差异。B组和C组之间的通畅率未发现显著差异。在D组中,植入后25周时,左右颈动脉和左右股动脉植入部位的通畅率最佳。当给予ASA和DIP 25周时,观察到最高的通畅率。